Course Title: Integrated Pharmaceutical Care Practice A

Part A: Course Overview

Course Title: Integrated Pharmaceutical Care Practice A

Credit Points: 12.00


Course Coordinator: .

Course Coordinator Phone: +61 3 9925

Course Coordinator Email: @rmit.edu.au


Pre-requisite Courses and Assumed Knowledge and Capabilities

Enforced Pre-Requisite Courses

Successful completion of:

Note: it is a condition of enrolment at RMIT that you accept responsibility for ensuring that you have completed the prerequisite/s and agree to concurrently enrol in co-requisite courses before enrolling in a course.

For information go to RMIT Course Requisites webpage.

 

Enforced Co-Requisite Courses

You should undertake the following courses at the same time as this course as it contains areas of knowledge and skills which are implemented together in practice.

Note: it is a condition of enrolment at RMIT that you accept responsibility for ensuring that you have completed the prerequisite/s and agree to concurrently enrol in co-requisite courses before enrolling in a course.

For information go to RMIT Course Requisites webpage.

 

 


Course Description

This course has been designed for you to apply your knowledge of therapeutics, pharmaceutics and dosage formulations in a patient centred setting to optimise therapeutic outcomes for patients. You will apply your knowledge of pharmaceutics to make recommendations for patients who require dose modifications or dosage form changes because of their age, disability or health condition. As part of this process, you will be able to identify any changes to pharmacokinetic or pharmacodynamic profiles of the medication and adjust the dose or medication accordingly. You will be able to formulate and make compounded medicines for this purpose and ensure stability profiles using the available literature. You will be able to assess the stability of medicines used in dose administration aids and make appropriate recommendations to ensure stability.  


Objectives/Learning Outcomes/Capability Development

Program Learning Outcomes 

This course contributes to the program learning outcomes for the following programs:  

Bachelor of Pharmacy (Hons) 

PLO 1 Apply breadth and depth of pharmaceutical and health science theories, concepts and evidence in various real world settings using a scientific approach to improve patient and population health.    

PLO 2 Apply and critically evaluate evidence-based pharmaceutical and health knowledge and skills to conceptualise and deliver safe and effective practice in a variety of contexts, independently and collaboratively, with emerging technological advancements 

PLO 4 Demonstrate the ability to generate and evaluate solutions to all aspects of interdisciplinary professional practice while complying with ethical, legal and regulatory standards that underpins the field of health science. 

PLO 5 Communicate to diverse audiences utilising contemporary and traditional formats employing integrity, inclusivity and culturally safe practices to ensure patient-centred care. 

PLO 6 Demonstrate responsibility and accountability for own learning, professional behaviour, reflective practice, and professional development as part of a multidisciplinary team 

PLO 8: Demonstrate an ability to formulate, prepare, and deliver medications, therapeutic products, and services according to ethical codes and practice guidelines 

 

For more information on the program learning outcomes for your program, please see the program guide. 


Upon successful completion of this course, you will be able to:  

  1. Assess the medication profile of a patient who requires therapeutic or dose modification or dosage form change and make evidence-based recommendations to ensure medication adherence.  
  2. Identify pharmacokinetic and pharmacodynamic consequences of dose modification or dose and make appropriate recommendations to ensure optimal therapy.  
  3. Formulate and compound dosage forms for use in selected patient population groups 
  4. Assess the stability of medications packed into dosage administration aids, determine the shelf life of the product, and make recommendations that ensure the expected therapeutic outcomes using the available literature. 


Overview of Learning Activities

 

You will be actively engaged in a range of learning activities such as lectorials, tutorials, practicals, laboratories, seminars, project work, class discussion, individual and group activities. Delivery may be face to face, online or a mix of both. 

You are encouraged to be proactive and self-directed in your learning, asking questions of your lecturer and/or peers and seeking out information as required, especially from the numerous sources available through the RMIT library, and through links and material specific to this course that is available through myRMIT Studies Course. 


Overview of Learning Resources

 

RMIT will provide you with resources and tools for learning in this course through myRMIT Studies Course. 

There are services available to support your learning through the University Library. The Library provides guides on academic referencing and subject specialist help as well as a range of study support services. For further information, please visit the Library page on the RMIT University website and the myRMIT student portal.


Overview of Assessment

Assessment Tasks 

This course contains hurdle requirements. All hurdle requirements for this course are indicated clearly in the assessment regime that follows, against the relevant assessment task(s) and all have been approved by the College Deputy Pro Vice-Chancellor (Learning & Teaching). 

Assessment Task 1:  Dose Modification Case Studies 

Weighting (20%) 

This assessment task supports CL01, CLO2, CLO3 

Assessment Task 2: Extemporaneous compounding practicals (4 practicals) 

Weighting (40%) The final practical will be a hurdle assessment 

This assessment task supports CLO1, CLO2, CLO3 

Assessment Task 3: Stability literature review 

Weighting (20%) 

This assessment task supports CLO4  

Assessment Task 4: End of semester test 

Weighting (20%) 

This assessment task supports CLO1, CLO2, CLO3, CLO4 

If you have a long-term medical condition and/or disability it may be possible to negotiate to vary aspects of the learning or assessment methods. You can contact the program coordinator or Equitable Learning Services if you would like to find out more.